{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:15:18Z","timestamp":1791321318972,"version":"4.3.1"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,9,11]]},"DOI":"10.1001\/jama.2018.12512","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T15:44:11Z","timestamp":1536767051000},"page":"995","source":"Crossref","is-referenced-by-count":197,"title":["Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation"],"prefix":"10.1001","volume":"320","author":[{"given":"Sarah","family":"Alexander","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya H.","family":"Gaur","sequence":"additional","affiliation":[{"name":"St Jude Children's Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, Benioff Children's Hospital, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doojduen","family":"Villa Luna","sequence":"additional","affiliation":[{"name":"Children's Oncology Group, Monrovia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha","family":"Dang","sequence":"additional","affiliation":[{"name":"University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"City of Hope, Duarte, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Green","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburg, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Nieder","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center and Research Institute, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Fisher","sequence":"additional","affiliation":[{"name":"Children's Healthcare of Atlanta, Egleston, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Charles","family":"Bailey","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wiernikowski","sequence":"additional","affiliation":[{"name":"McMaster Children's Hospital, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Child Health Evaluation Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Children\u2019s Oncology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"joi180094r1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00431-015-2525-5","article-title":"Bloodstream infection in paediatric cancer centres\u2014leukemia and relapsed malignancies are independent risk factors.","volume":"174","author":"Ammann","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"1","key":"joi180094r3","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/MPH.0b013e31822817a6","article-title":"Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children\u2019s Oncology Group.","volume":"34","author":"Sung","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"joi180094r4","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"joi180094r5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(ISSN)1545-5017","article-title":"A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia.","volume":"43","author":"Yousef","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"joi180094r6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cncr.v113:2","article-title":"Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.","volume":"113","author":"Kurt","year":"2008","journal-title":"Cancer"},{"issue":"13","key":"joi180094r7","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/cncr.28688","article-title":"Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.","volume":"120","author":"Inaba","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"joi180094r8","doi-asserted-by":"publisher","first-page":"e26952","DOI":"10.1002\/pbc.v65.5","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.","volume":"65","author":"Sulis","year":"2018","journal-title":"Pediatric Blood Cancer"},{"issue":"11","key":"joi180094r9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"joi180094r10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/cncr.28524","article-title":"Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.","volume":"120","author":"Yeh","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"joi180094r11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/pbc.v59.1","article-title":"Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?","volume":"59","author":"Alexander","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"joi180094r12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/17474086.2014.965140","article-title":"Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.","volume":"7","author":"Lehrnbecher","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"35","key":"joi180094r14","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation.","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"joi180094r18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1128\/CMR.15.4.613-630.2002","article-title":"What happened to the streptococci: overview of taxonomic and nomenclature changes.","volume":"15","author":"Facklam","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"joi180094r19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/590167","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"joi180094r20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"joi180094r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis.","volume":"48","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"joi180094r23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.441","article-title":"Clostridium difficile infection in children.","volume":"167","author":"Sammons","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"6","key":"joi180094r24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"joi180094r25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/cid\/ciw113","article-title":"Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009-2012.","volume":"62","author":"See","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"joi180094r26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/INF.0b013e3180cc20e4","article-title":"Will fluoroquinolones ever be recommended for common infections in children?","volume":"26","author":"Schaad","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"joi180094r27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/INF.0b013e3180cbd382","article-title":"Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.","volume":"26","author":"Noel","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"joi180094r28","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1542\/peds.2013-3636","article-title":"Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin.","volume":"134","author":"Bradley","year":"2014","journal-title":"Pediatrics"},{"key":"joi180094r2","volume-title":"Bacterial Infections. Thomas\u2019 Hematopoietic Cell Transplantation","author":"Leather","year":"2015","edition":"5th ed"},{"key":"joi180094r15","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute"},{"key":"joi180094r21","volume-title":"Statistical Monitoring of Clinical Trials: A Unified Approach","author":"Proschan","year":"2006"},{"key":"joi180094r13","unstructured":"FDA Drug Safety Communication. FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm511530.htm. May 12, 2016. Accessed August 23, 2018."},{"key":"joi180094r16","unstructured":"National Cancer Institute. CREP Cancer Therapy Evaluation Program web page. Common terminology criteria for adverse events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Updated March 1, 2018. Accessed August 17, 2018."},{"key":"joi180094r17","unstructured":"National Healthcare Safety Network. Centers for Disease Control and Prevention web page. Central line\u2013associated bloodstream infection (CLABSI) and non-central line\u2013associated bloodstream infection. https:\/\/www.cdc.gov\/nhsn\/acute-care-hospital\/clabsi\/index.html. 2017 Accessed August 23, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/320\/10\/995\/17684436\/jama_alexander_2018_oi_180094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T11:00:41Z","timestamp":1562065241000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.12512"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,9,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.12512","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734004427.793567068","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,11]]}}}